SynthesisJournal of neurology2025

Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson's disease.

Marwah Bintay Khalid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.